Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H36O4 |
| Molecular Weight | 448.5937 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 8 / 8 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)CC[C@]5(C)[C@@]4([H])CC[C@]3(C)[C@@]1(O[C@@](C)(O2)C6=CC=CC=C6)C(C)=O
InChI
InChIKey=AHBKIEXBQNRDNL-FVCOMRFXSA-N
InChI=1S/C29H36O4/c1-18(30)29-25(32-28(4,33-29)19-8-6-5-7-9-19)17-24-22-11-10-20-16-21(31)12-14-26(20,2)23(22)13-15-27(24,29)3/h5-9,16,22-25H,10-15,17H2,1-4H3/t22-,23+,24+,25-,26+,27+,28-,29-/m1/s1
Algestone acetophenide, also known as dihydroxyprogesterone acetophenide, is an agonist of the progesterone receptor. Algestone acetophenide in combination with estradiol enanthate is sold under the brand name Deladroxate as a form of long-lasting injectable birth control. The combination provides simultaneously prolonged progestational and estrogenic activities both of which are maintained at effective levels for approximately three weeks after the intramuscular injection of a single dose.
Approval Year
Sample Use Guides
On the eight day (7th-9th) after the onset of menstruation from the last ovulatory cycle, one ml.of Deladroxate (150 mg of dihydroxyprogesterone acetophenide combined with 10 mg of estradiol enanthate) was injected intramuscularly in the deltoid or gluteal region.
Route of Administration:
Intramuscular
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C776
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID1022891
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
C90968
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
5284538
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
759863
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
100000077972
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
OL7KC2O3OT
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105993
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
SUB12773MIG
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
246-195-8
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
24356-94-3
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
ALGESTONE ACETOPHENIDE
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
D000463
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
797
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | |||
|
m1503
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY | Merck Index | ||
|
49327
Created by
admin on Fri Dec 15 15:05:33 GMT 2023 , Edited by admin on Fri Dec 15 15:05:33 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
